Protective Effect of Renshen Sinitang and Its Active Ingredients on Myocardial Cell Injury Induced by Pentobarbital Sodium

Shuo LI; Ping SU; Guang-ping ZHANG; Teng-fei CHEN; Li-na MA; Han LI; Hong-ping HOU; Zhong-xiu ZHANG; Yi-fei YANG; Yun-hang GAO; Ling SONG; Zu-guang YE

doi:10.13422/j.cnki.syfjx.20190124

您当前的位置：

首页 >

文章列表页 >

Protective Effect of Renshen Sinitang and Its Active Ingredients on Myocardial Cell Injury Induced by Pentobarbital Sodium

Classic Prescriptions | 更新时间：2021-02-09

- Protective Effect of Renshen Sinitang and Its Active Ingredients on Myocardial Cell Injury Induced by Pentobarbital Sodium
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 1, Pages: 90-95(2019)
- 作者机构：
  
  1.辽宁师范大学　生命科学学院，辽宁　大连　 116000
  2.中国中医科学院　中药研究所，北京　 100075
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20190124
  CLC： R2-0;R22;R285.5;R289
- Received：10 August 2018，
  
  Published Online：19 October 2018，
  
  Published：05 January 2019
- 稿件说明：
移动端阅览
Shuo LI, Ping SU, Guang-ping ZHANG, et al. Protective Effect of Renshen Sinitang and Its Active Ingredients on Myocardial Cell Injury Induced by Pentobarbital Sodium[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(1): 90-95.
DOI：

Shuo LI, Ping SU, Guang-ping ZHANG, et al. Protective Effect of Renshen Sinitang and Its Active Ingredients on Myocardial Cell Injury Induced by Pentobarbital Sodium[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(1): 90-95. DOI： 10.13422/j.cnki.syfjx.20190124.

摘要

目的：

探讨人参四逆汤及其有效成分对戊巴比妥钠所致心肌细胞损伤的保护作用及其机制。

方法：

H9C2细胞经传代培养后，分别给予人参皂苷Rb

0.01，0.1，1 μmol·L

－1

，Re 0.01，0.1，1 μmol·L

－1

，异甘草素（isoliquiritigenin

ISL）20，40，80 μmol·L

－1

，甘草次酸（glycyrrhetinic acid

GA）10，20，40 μmol·L

－1

，人参四逆汤10

100

400 mg·L

－1

，作用4 h，经0.1%的戊巴比妥钠作用30 min后，检测细胞存活率，乳酸脱氢酶（lactate dehydrogenase

LDH），脂质过氧化物丙二醛（malondialdehyde

MDA），Na

-K

-三磷酸腺苷（ATP）酶，Ca

-ATP酶活性，同时采用实时荧光定量聚合酶链式反应（Real-time PCR）检测过氧化物酶体增殖活化受体共激活因子-1

（peroxisome proliferative activated receptor

PGC-1

），B淋巴细胞瘤-2相关X蛋白（Bax），半胱氨酸蛋白酶-3（Caspase-3） mRNA的表达情况。

结果：

人参四逆汤及其有效成分对心衰细胞模型有保护作用，与正常组比较，模型组细胞存活率显著下降，LDH

MDA含量显著升高，Na

-K

-ATP酶活性升高，Ca

-ATP酶活性显著降低，PGC-1

mRNA表达下调，Bax

Caspase-3 mRNA表达（

0.01），证明模型成立。与模型组比较，各给药组显著升高细胞存活率，降低LDH

MDA含量，抑制Na

-K

-ATP酶活性，提高Ca

-ATP酶活性，上调PGC-1

mRNA表达，抑制Bax

Caspase-3 mRNA表达（

0.05

0.01）。

结论：

人参四逆汤及其有效成分对心衰细胞模型有显著保护作用，且其作用机制与抗氧化，改善线粒体能量代谢，抑制线粒体凋亡途径有关。

Abstract

Objective:

To explore the protective effect and mechanisms of Renshen Sinitang and its active ingredients on cardiomyocyte injury induced by pentobarbital sodium.

Method:

H9C2 cells were sub-cultured with ginsenoside Rb

0.01

0.1

1 μmol·L

-1

Re 0.01

0.1

1 μmol·L

-1

isoliquiritigenin 20

80 μmol·L

-1

glycyrrhetinic acid 10

40 μmol·L

-1

Renshen Sinitang

100

400 mg·L

-1

for 4 h. After treatment with 0.1% of sodium pentobarbital for 30 min

cell viability

lactate dehydrogenase (LDH)

lipid peroxide malondialdehyde (MDA)

-K

-adenosine triphosphate(ATP)ase

-ATPase activity

and real-time fluorescence quantitative polymerase chain reaction (Real-time PCR) were used to detect the expressions of peroxisome proliferative activated receptor-1

(PGC-1

)

B-cell lymphoma-2 associated X protein(Bax) and cysteine aspartate-specific protease-3(Caspase-3) mRNA.

Result:

Renshen Sinitang and its active ingredients have a protective effect on heart failure cell model. Compared with the normal group

the cell survival rate of the model group decreased significantly

while the LDH and MDA contents increased significantly

and the Na

-K

-ATPase activity increased. Ca

-ATPase activity was significantly decreased

PGC-1

mRNA expression was down-regulated

Bax and Caspase-3 mRNA expressions indicates the modeling(

0.01) . Compared with the model group

each administration group showed a significantly increased cell viability

decreased LDH

MDA content

inhibited Na

-K

-ATPase activity

increased Ca

-ATPase activity

up-regulated PGC-1

mRNA expression

and inhibited Bax and Caspase-3 mRNA expression (

0.05

0.01).

Conclusion:

Renshen Sinitang and its active ingredients have a significant protective effect on heart failure cell model

and its mechanisms of action are related to anti-oxidation

improvement of mitochondrial energy metabolism and inhibition of mitochondrial apoptosis pathway.

关键词

Keywords

references

Brown D A , Perry J B , Allen M E ,et al . Mitochondrial function as a therapeutic target in heart failure [J]. Nat Rev Cardiol , 2017 , 14 ( 4 ): 238 - 250 .

孟永梅，王伟，叶会玲．慢性心力衰竭的中医研究概况 [J]．中华中医药杂志， 2012 ， 27 ( 3 ): 670 - 674 .

蒋梅先．浅谈慢性心力衰竭防治中的中医药加载治疗 [J]．辽宁中医杂志， 2014 ， 41 ( 8 ): 1553 - 1555 .

LI X L , ZHANG J , HUANG J ,et al . A multicenter randomized double-blind parallel-group placebo-controlled study of the effects of Qiliqiangxin capsules in patients with chronic heart failure [J]. J Am Coll Cardiol , 2013 , 62 ( 12 ): 1065 - 1072 .

杨海润，孙建宁，张广平，等．四逆汤组方不同配伍毒效关系研究 [J]．中国实验方剂学杂志， 2013 ， 19 ( 23 ): 266 - 269 .

贺金，方艳伟，李永民．四逆汤对大鼠心肌缺血损伤的保护作用 [J]．中华中医药杂志， 2008 ， 2 ( 7 ): 638 - 640 .

翟建英，靳冉，朱晓光，等．四逆汤及其组分配伍对心力衰竭大鼠血流动力学的影响 [J]．中西医结合心脑血管病杂志， 2013 ， 11 ( 12 ): 1480 - 1482 .

缪萍，裘福荣，曾金，等．四逆汤及其不同配伍方对心力衰竭大鼠的保护作用及机制探讨 [J]．中国实验方剂学杂志， 2015 ， 21 ( 5 ): 138 - 142 .

王雪梅，刘佳，付殿斌，等．参附汤萃取液成分对阿霉素致心衰大鼠血流动力学、心肌自噬及凋亡的影响 [J]．陕西中医学院学报， 2014 ， 37 ( 4 ): 75 - 78 .

李梦婷，彭成，谢晓芳．心力衰竭小型动物模型研究进展 [J]．中国实验方剂学杂志， 2018 ， 24 ( 5 ): 213 - 219 .

谢晓芳，徐菲菲，彭成，等．人参皂苷类成分对戊巴比妥钠损伤心肌细胞ATP 酶及相关离子的影响 [J]．中药药理与临床， 2014 ， 30 ( 5 ): 61 - 64 .

贺抒，谢晓芳，张雪，等．附子水溶性生物碱对心衰细胞模型的治疗作用 [J]．中国实验方剂学杂志， 2014 ， 20 ( 16 ): 127 - 130 .

LU X , XIONG Z , LI J ,et al . Metabonomic study on′Kidney-Yang deficiency syndrome and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry [J]. Talanta , 2011 , 83 ( 3 ): 700 - 708 .

YANG M , CHEN J L , XU L W ,et al . Navigating traditional Chinese medicine network pharmacology and computational tools [J]. Evid Based Complement Alternat Med , 2013 , doi: 10.1155/2013/731969 http://doi.org/10.1155/2013/731969 .

CHEN R , Moriya J , Yamakawa J , et al . Traditional Chinese medicine for chronic fatigue syndrome [J]. Evid Based Complement Alternat Med , 2010 , 7 ( 1 ): 3 - 10 .

徐雅娟，赵宏峰，司云珊，等．人参四逆汤活性成分的分离和鉴定 [J]．中草药， 2002 ， 33 ( 3 ): 203 - 204 .

Tornroth-Horsefield S , Neutze R. Opening and closing the metabolite gate [J]. Proc Natl Acad Sci USA , 2008 , 105 ( 50 ): 19565 - 19566 .

沈放，杨黎江，路斌，等．海枫藤提取物对Na + -K + -ATP酶活力的影响 [J]．时珍国医国药， 2008 ， 19 ( 8 ): 1959 - 1960 .

徐菲菲，彭成，谢晓芳，等．参附注射液对戊巴比妥钠致心衰模型心肌细胞膜ATP 酶和相关离子的影响 [J]．中国实验方剂学杂志， 2013 ， 19 ( 7 ): 196 - 199 .

胡元会，车维新，曹雪滨，等．心复康口服液对大鼠实验心衰模型心肌细胞Ca 2+ -ATP酶及琥珀酸脱氢酶活性的影响 [J]．中国医药学报， 2000 ， 15 ( 2 ): 31 .

李超，伏圣博，刘华玲，等．细胞凋亡研究进展 [J]．世界科技研究与发展， 2007 ， 29 ( 3 ): 45 - 53 .

张晓华，刘淑荣，钱锋，等．强心康颗粒对慢性心衰大鼠心肌细胞病理形态学腺苷酸转位酶，PGC-1 α mRNA 表达的影响 [J]．中国实验方剂学杂志， 2018 ， 24 ( 9 ): 121 - 126 .

Arany Z , Novikov M , Chin S ,et al . Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha [J]. Proc Natl Acad Sci USA , 2006 , 103 ( 26 ): 10086 - 10091 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of Potential Active Components and Molecular Mechanism of Baoxin Granules Regulating Ferroptosis in Treatment of Heart Failure

Effect of Qingxin Jieyu Granules Regulating Mitophagy on Ventricular Remodeling After Myocardial Infarction of C57B/L6 Mice

Material Basis and Its Distribution in vivo of Qili Qiangxin Capsules Analyzed by UPLC-Q-Orbitrap-MS

Effect of Serum Containing Zhenwutang on Apoptosis of Myocardial Mast Cells and Mitochondrial Autophagy

Role of Mitophagy in Prevention and Treatment of Heart Failure Based on PINK1/Parkin Pathway and Treatment with Traditional Chinese Medicine： A Review

Related Author

CHEN Yu

WANG Maolin

WANG Yun

ZHAO Yifan

XU Jing

WU Hongwei

WANG Fang

ZHAO Xiaoang

Related Institution

Jiangxi University of Chinese Medicine

Center for Food Evaluation，State Administration for Market Regulation

Jiangxi Province Key Laboratory of Traditional Chinese Medicine（TCM） Pharmacology，Institute of TCM Health Industry，China Academy of Chinese Medical Sciences

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences

Xiyuan Hospital， China Academy of Chinese Medical Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰